In contrast, an increase in Mei-P26 levels inhibits growth of epithelial cells in these two conditions. Upon depletion of Brat, Mei-P26 up-regulation prevents an increase in dMyc protein levels and leads to tissue undergrowth. This mechanism appears to be tissue-specific since Mei-P26 is not upregulated in brain tumors resulting from brat loss-of-function. Driving Mei-P26 expression in these tumors -mimicking the situation in epithelial cells-is sufficient to prevent dMyc accumulation, thus rescuing the overgrowth. Finally, we show that Mei-P26 upregulation mediates dMyc-induced apoptosis and limits dMyc growth potential in epithelial cells. These findings shed light on the tumor suppressor roles of TRIM-NHL proteins and underscore a new mechanism that maintains tissue homeostasis upon dMyc deregulation. 4
Introduction
TRIM-NHL proteins, which are present in many animal species ranging from C. elegans to mammals, are characterized by the presence of a tripartite motif, namely RING, B-box and coilcoiled domains, in their N-terminal. The RING domain confers these proteins E3-ubiquitin ligase activity (Meroni and Diez-Roux, 2005) . In the C-terminal part, these proteins carry several repeats of a NHL domain (first identified in NCL-1, HT2A and LIN-41 proteins; Slack and Ruvkun, 1998) , which mediate specific protein-protein interactions and translational inhibition (Loedige et al., 2013; Sonoda and Wharton, 2001 ). The highly conserved structure of these proteins points to common biological functions, such as the regulation of asymmetric cell division or microRNA levels (Hammell et al., 2009; Kohlmaier and Edgar, 2008; Loedige and Filipowicz, 2009; Neumüller et al., 2008; Schwamborn et al., 2009) . TRIM-NHL proteins have also been shown to act as translational inhibitors (Harris et al., 2011; Loedige et al., 2013; Sonoda and Wharton, 2001) . Of the four members present in Drosophila, Brat and Mei-P26 act as tumor suppressors in stem cell lineages, as mutations in these two proteins give rise to tumor formation in the brain and in the germline, respectively (Arama et al., 2000; Page et al., 2000) .
During the cell division of larval neuroblasts, the asymmetric segregation of Brat promotes differentiation and inhibits cell growth and proliferation (Bello et al., 2006; Betschinger et al., 2006; Lee et al., 2006) . Consequently, brat loss-of-function results in the malignant proliferation of a subset of neural progenitors at the expense of differentiated neurons (Bowman et al., 2008) .
Similarly, Mei-P26 activity in transit-amplifying cells in the female germline inhibits cell growth and proliferation and promotes differentiation (Neumüller et al., 2008) . A recent study also unraveled a tumor suppressor function for TRIM3 in mammals (Liu et al., 2014) , suggesting that this role might constitute a key feature of TRIM-NHL proteins. Studies in stem cell lineages have proposed that both Brat and Mei-P26 inhibit cell growth by repressing the proto-oncogene dMyc (Betschinger et al., 2006; Neumüller et al., 2008) . Interestingly, their closest mammalian ortholog, TRIM32, also prevents the self-renewal of mouse neural progenitors and induces neuronal differentiation by targeting c-Myc for degradation (Schwamborn et al., 2009 ).
The conserved transcription factor Myc is a key regulator of many biological activities (Gallant, 2013) . It also functions as an oncogene that contributes to the formation of many human cancers and thus constitutes a therapeutic target (Dang, 2012; Vita and Henriksson, 2006) . As such, it has been extensively studied both in developmental and cancer biology. In Drosophila, dMyc promotes cell growth and ribosome biogenesis (Grewal et al., 2005; Johnston et al., 1999) . In addition, as in mammalian tumors, dMyc overexpression also induces apoptosis through an unknown mechanism (Montero et al., 2008) . This dual role of dMyc in triggering both cell growth and cell death has been proposed to be responsible for the maintenance of final tissue size (de la Cova et al., 2004) .
The complex relationship between growth and differentiation in stem cell lineages makes it difficult to study the interaction between TRIM-NHL proteins and dMyc specifically and exclusively in growth control. We therefore addressed this question in a highly proliferating epithelial tissue, the wing primordium. The development of this tissue has the advantage that growth and differentiation are separated in time: growth takes place mainly during the juvenile period (larval stages), while differentiation is restricted to metamorphosis (Cohen, 1993) . Our results reveal that, unlike stem cell lineages, epithelial cells possess a tissue-specific mechanism based on the interaction between TRIM-NHL tumor suppressors and the dMyc proto-oncogene.
Modifications of Mei-P26 levels appear to constitute a safety mechanism that helps to maintain tissue homeostasis upon brat loss-of-function and dMyc overexpression.
Material and Methods

Drosophila strains
UAS-Mei-P26
∆NHL (kind gift from S.M. Cohen, (Li et al., 2012) 
Immunohistochemistry and In Situ Hybridization
For the overexpression of Mei-P26, larvae were raised at 18ºC and exposed to 29ºC 18 h before dissection in order to potentiate the UAS-Gal4 system. To generate MARCM clones, a heatshock of 45 min at 37ºC was given during early second instar to the following genotypes: (1) TUNEL staining and in situ hybridizations were performed as previously described (Herranz et al., 2010) . Figure 1D ).
These results imply a conserved role of Brat in the negative regulation of dMyc translation, in both neural progenitors and epithelial cells.
The vertebrate TRIM-NHL protein TRIM32 displays ubiquitin ligase activity and binds and targets c-Myc for degradation (Schwamborn et al., 2009) . Similarly, the overexpression of Mei-P26, the Drosophila ortholog of TRIM32 (Page et al., 2000) , strongly reduces dMyc protein levels in a proteasome-dependent manner ((Herranz et al., 2010) , see also Figure S2A ). In contrast, overexpressing a form of Mei-P26 lacking the NHL domain, which mediates specific protein-protein interactions, did not affect dMyc levels ( Figure S2B ). Equivalent amounts of fulllength Mei-P26 and the truncated version were found to be expressed with the GAL4/UAS system in the Drosophila ovary (Li et al., 2012) . Thus, both the ubiquitin ligase activity (Herranz et al., 2010) and the NHL domain (this work) of Mei-P26 are required to target dMyc for degradation. These observations confirm that the overexpression of Brat or Mei-P26 also reduces dMyc levels in epithelial cells, acting at the mRNA and protein levels, respectively.
Brat depletion does not affect dMyc protein levels and does not cause tissue overgrowth
Consistent with the repression of the dMyc-3'UTR sensor upon Brat overexpression, dMyc protein levels were also diminished when compared to neighboring wild-type cells ( Figure 1E , F). By using two different Gal4 lines to overexpress Brat in specific territories of the wing, we found that increased Brat levels lead to smaller wings (Figure S1B function in epithelial cells has no effect on dMyc protein levels and causes tissue undergrowth.
We next addressed the molecular bases mediating the tissue-specific activities of Brat.
Mei-P26 mediates tissue undergrowth and prevents dMyc up-regulation upon depletion of brat in epithelial cells
The observation that the dMyc-3'UTR sensor, but not dMyc protein, is up-regulated in epithelial cells in the absence of Brat suggests that dMyc is finely regulated at the protein level in this condition. Interestingly, we observed an increase in Mei-P26 protein levels in brat 192 mutant as well as in brat
RNAi
-expressing cells when compared to the wild-type neighboring tissue ( Figure   2A , B). Moreover, the depletion of Brat led to increased mei-P26 mRNA levels ( Figure 2C , C').
Brat binds AGO1 (Neumüller et al., 2008) , and several TRIM-NHL proteins regulate microRNAs (Hammell et al., 2009; Neumüller et al., 2008; Schwamborn et al., 2009 ). Since
Mei-P26 is controlled by several miRNAs in the wing epithelium (Herranz et al., 2010), we addressed whether Brat modulates Mei-P26 levels by regulating microRNAs. We found no changes in mature miRNA levels ( Figure S3A ) or in the activity of the well-described growth- Figure 3C ). Instead, we observed a decrease in Mei-P26 levels in this condition ( Figure 3C ), consistent with the fact that Mei-P26 is normally expressed in differentiating neurons (Neumüller et al., 2008) and that neurons fail to differentiate in overgrowing brat mutant clones (as seen by the absence of cells positive for the neuronal marker Elav, Figure 3D ).
Driving the expression of Mei-P26 in brat mutant clones was sufficient to significantly rescue the overgrowth phenotype ( Figure 3A '',B) and prevent dMyc up-regulation ( Figure 3A '') 72 h and 96 h after induction. However, neural progenitors still failed to differentiate, as reflected by the absence of Elav-positive neurons ( Figure 3D' ). Thus, Mei-P26 can also prevent the overgrowth of brat mutant cells in the neural lineage, most probably through the inhibition of dMyc rather than by driving cell differentiation. These results also illustrate that tumorous overgrowth can be uncoupled from differentiation in neural progenitors.
We propose that this tissue-specific regulation of Mei-P26 by Brat accounts for the opposite growth phenotypes observed in the neural lineage and in the wing epithelium. While in stem cell lineages the depletion of brat or mei-P26 alone is suficient to induce dMyc upregulation, the crosstalk between the two TRIM-NHL proteins in epithelial cells adds another layer of control to prevent an increase in dMyc levels and in cell and tissue size ( Figure 3E ).
Mei-P26 up-regulation maintains tissue homeostasis upon dMyc overexpression
Although dMyc is a cellular growth promoter, as shown by its ability to increase cell size when overexpressed (quantified as cell density in Figure 4A ; The oncogene Myc has been extensively studied in mammals for its role in normal conditions and in tumorigenesis (Eilers and Eisenman, 2008) . In normal cells, an increase in Myc levels promotes growth but concomitantly activates safety mechanisms-such as apoptosis or increased dependency on nutrients-that maintain tissue homeostasis. Hence, the tumorigenic potential of Myc overexpression requires additional mutations that disable these mechanisms. In line with this, we and others have observed that dMyc overexpression in the wing primordium of Drosophila promotes cell growth but does not cause tissue overgrowth. These findings suggest that epithelial cells also activate such safety mechanisms. Here we show that dMyc overexpression triggers a strong up-regulation of Mei-P26, thereby establishing a feedback mechanism between the two factors. Increased Mei-P26 levels limit dMyc growth potential and mediate dMyc-induced apoptosis. The activation of Mei-P26 by dMyc provides a new mechanism that contributes to tissue homeostasis in dMyc-overexpressing epithelial cells.
We observed that the capacity of overexpressed dMyc to drive tissue growth in the absence of Mei-P26 was still limited, opening the possibility that other homeostatic mechanisms limiting dMyc activity might be at play in epithelial cells. A feedback mechanism between dMyc and Yorkie, the Drosophila homolog of the Hippo pathway transducer, has also been proposed to regulate tissue size (Neto-Silva et al., 2010) . dMyc overexpression reduces the levels of Yorkie, a potent inducer of tissue growth and inhibitor of apoptosis. Thus, both Mei-P26 up-regulation and Yorkie down-regulation contribute to dMyc-induced apoptosis and limit dMyc potential to drive cell and tissue growth.
To date, Mei-P26 has been shown to negatively regulate tissue growth by degrading the dMyc protein (Herranz et al., 2010) . Our results suggest that other molecular effectors are involved in this process. We observed that increased Mei-P26 levels are responsible for tissue and cell undergrowth upon depletion of Brat. However, dMyc protein levels remain unchanged in this condition, pointing to a dMyc-independent role of Mei-P26 in inhibiting cell growth.
Furthermore, we show that Mei-P26 antagonizes dMyc-induced cell growth and mediates dMycinduced apoptosis, thereby preventing tissue overgrowth upon dMyc overexpression in epithelial cells. The challenge is now to further characterize the mechanisms by which Mei-P26 regulates cell growth and apoptosis and thus provide greater insight into the homeostasis of epithelial tissues.
In conclusion, the use of the wing epithelium as a model system has allowed us to analyze the participation of Brat, Mei-P26, and dMyc in growth control. Surprisingly, we have observed that brat loss-of-function and dMyc overexpression have a negative impact on growth in this tissue.
In both cases, we have identified the up-regulation of Mei-P26 to be responsible for the tissuespecific growth alteration. A previous study also identified Mei-P26 as a target of the miRNA machinery and showed that the depletion of the miRNA machinery in the wing disc causes undergrowth as a result of increased Mei-P26 levels (Herranz et al., 2010) . The observation that
Mei-P26 mediates the response to perturbations opens up the possibility that modulations of Mei-P26 levels serve to maintain the homeostasis of epithelial tissues.
tumorigenesis. Yet, abnormal cell proliferation and tissue growth also activate well-described tumor suppressor mechanisms preventing neoplastic growth, such as oncogene-induced cell death (Lowe et al., 2004) . The formation of a malignant tumor therefore requires additional mutations that disable these tumor suppressor mechanisms. Different types of tumors display different oncogenic signatures, which are suggestive of tumor-specific therapies (Ciriello et al., 2013) . The sensitivity to a given oncogene therefore varies from one tissue to another and may depend on the activation -or not-of tissue-specific tumor suppressive mechanisms. Our study illustrates how the interplay between oncogenes and tumor suppressors can mediate tissuespecific responses to genetic alterations in terms of growth and apoptosis. 
